Searchable abstracts of presentations at key conferences in endocrinology

ea0026p409 | Thyroid (non cancer) | ECE2011

The induction of hyperthyroidism in patient with non-toxic goiter after radioiodine therapy: a case report

Abdelrazek Saeid , Rogowski Franciszek

A 44-year-old female, with non-toxic goiter was referd to our Department for thyroid volume reduction. Serum levels of FT4, FT3 and TSH were within normal range, high resolution ultrasonography show enlarlarged thyroid glands (50 ml), with 2 nodules one in the left and one in the right lobe. Malignancy was ruled out by ultrasound-guided fine-needle aspiration biopsy. Thyroid radioiodine scintigraphy showed homogenous and diffuse uptake in the right lobe, ...

ea0026p408 | Thyroid (non cancer) | ECE2011

The effect of radioiodine therapy in patients with non-toxic goiter with hot nodules on thyroid scan

Abdelrazek Saeid , Rogowski Franciszek , Szelachowska Malgorzata , Szorc Malgorzata , Mojsak Malgorzata

Radioiodine therapy is non-invasive, safe and cost effective method of therapy for reduction of goitre. We aimed to determine whether radioiodine therapy has benefit effect on the symptoms mimicking hyperthyroidism in nontoxic goitre patients.Material and methods: We studied 20 patients with non toxic nodular goitre, aged 42–79 years, 12 females and 8 males. All the patients complained of some symptoms of hyperthyroidism (palpitation, hot intoleranc...

ea0026p407 | Thyroid (non cancer) | ECE2011

The outcome of radioiodine therapy after 10 years in patient with toxic nodular goiter

Abdelrazek Saeid , Rogowski Franciszek , Szumowski Piotr , Szorc Malgorzata , Gorska Maria , Szelachowska Malgorzata

We treated 4150 patients, aged 30–70 years; 1950 patient with toxic multinodular goitre (TMNG), and 2200 patient with autonomous toxic nodule (ATN). Qualification of these patients was based on high levels of serum fT3 and fT4, low levels of serum TSH. Malignant changes were excluded in all nodules by fine needle aspiration biopsy. All the patients had serum TSH levels ≤0.1 mU/l and the effective T-half was ≥3 days at the time of treatmen...

ea0022p859 | Thyroid | ECE2010

The influence of radioiodine therapy on some parameters of oxidant/antioxidant balance in patients with Graves’ disease

Abdelrazek Saeid , Rogowski Franciszek , Zonenberg Anna , Szelachowska Malgorzata , Gorska Maria , Frackiel Malgorzata , Nikolajuk Agnieszka , Szumowski Piotr

Oxidative stress plays an important role in hyperthyroidism-induced tissue damage. We aimed to determine whether radioiodine therapy has benefit effect on the oxidant and antioxidant status in patients with Graves’ Disease.Material and methods: We studied 30 patients with Graves’ disease, aged 18–48 years. 12 normal adult volunteers were studied as control group. All the patients were treated unsuccessfully by antithyroid drugs. The effect...

ea0022p863 | Thyroid | ECE2010

The influence of radioiodine therapy in patient with non-toxic goiter with low RAIU in the enlarged nodule: a case report

Abdelrazek Saeid , Rogowski Franciszek , Parfienczyk Adam , Frackiel Malgorzata , Szelachowska Malgorzata , Siewko Katarzyna

A young woman aged 23 years, with non-toxic goiter was treated in our Department. Serum levels of FT4, FT3 and TSH were within normal range, high resolution ultrasonography show very large glands (60 ml), with large nodule in left lobe and smaller one in the right lobe. Malignancy was ruled out by ultrasound-guided fine-needle aspiration biopsy. Thyroid radioiodine scintigraphy showed homogenous and diffuse uptake in the right lobe, with very low uptake i...

ea0016p804 | Thyroid | ECE2008

The effect of radioiodine therapy in patient with non-toxic goitre after pre-treatment with a single dose of recombinant human thyroid stimulating hormone (rhTSH)

Abdelrazek Saeid , Parfienczyk Adam , Rogowski Franciszek , Szumowski Piotr , Kociura-Sawicka Agnieszka , Wojno Emilia

The aim of our study was to assess the effectiveness of radioiodine therapy (RIT) on the reduction of thyroid volume after pre-treatment adjunct of rhTSH in patients with non-toxic goitre with low RAIU.Material and methods: We treated 36 patients; (28 female, 8 male) aged 35–77 years. Initial 24 h RAIU was ranged between 5 and 17%, and thyroid volume ranged between 42 and 128 ml. Twelve patients had compressive symptoms. Malignant changes were exclu...

ea0022p858 | Thyroid | ECE2010

The evaluation of radioiodine therapy out come after five years in patient with subclinical hyperthyroidism

Abdelrazek Saeid , Rogowski Franciszek , Parfienczyk Adam , Szelachowska Malgorzata , Franckiel Malgorzaea , Zonenberg Anna , Karolczuk-Zarachowicz Malgorzata , Szumowski Piotr

Aim: The aim of our study was to evaluate the short-term (5 years) effect of radioiodine therapy (RAIT) on the achievement of euthyroidism, and prevention evolvement to overt hyperthyroidism.Material and methods: We treated 150 patients, aged 30–70 years; 54 patients with multinodular goitre (MNG), and 96 patients with autonomous nodule (ATN). Malignant changes were excluded in all nodules by fine needle aspiration biopsy. All the patients had serum...

ea0020p156 | Thyroid | ECE2009

Analysis of ghrelin and obestatin levels in children with thyroid disease

Bossowski Artur , Sawicka Beata , Szalecki Mieczyslaw , Urban Miroslawa , Rogowski Franciszek , Koput Alicja , Zelazowska-Rutkowska Beata , Tobolczyk Jolanta

Thyroid disease let to change of weight – in hyperthyroid body mass is reduced, but in hypothyroid it is increased. Recently researches suggest that many new bioactive substances, like ghrelin and obestatin, play a role in regulation of body mass. These closely related hormones have paradoxically different effects- ghrelin increases, but obestatin decreases appetite. The aim of the study was to evaluate ghrelin and obestatin levels in young patients with untreated Graves&...

ea0016p760 | Thyroid | ECE2008

The influence of radioiodine therapy on some parameters of oxidant/antioxidant balance in patients with subclinical hyperthyroidism

Abdelrazek Saeid , Rogowski Franciszek , Zonenberg Anna , Szelachowska Malgorzata , Parfienczyk Adam , Nikolajuk Agnieszka , Szumowski Piotr , Wojno Emilia , Frackiel Malgorzata

Oxidative stress plays an important role in hyperthyroidism induced – tissue damage.We aimed to determine whether radioiodine therapy (RIT) has benefit effect on the oxidant and antioxidant status in subclinical hyperthyroidism.Material and methods: We studied 40 patients with untreated subclinical hyperthyroidism, (33 female, 7 male), aged 23–78 years; 14 patients with multinodular goitre, and 25 patients with solitary a...

ea0016p789 | Thyroid | ECE2008

Radioiodine therapy in patients with toxic nodular goitre

Abdelrazek Saeid , Rogowski Franciszek , Zonenberg Anna , Parfienczyk Adam , Szelachowska Malgorzata , Gorska Maria , Szumowsk Piotr , Wojno Emilia , Frackieli Malgorzata , Karpinska Urszula

The aim of our study was to assess the effectiveness of radioiodine therapy (RIT) on the achievement of euthyroidism and reduction of thyroid volume, in patients with toxic nodular goitre (TNG).Material and methods: During the last 7 years, we treated 3800 patients with TNG, aged 30-70 years; 82% female and 18% male; 2200 patients with multinodular goitre (MNG) and 1600 with autonomous toxic nodule (ATN); thyroid volume ranged between 16 and 130 ml (30% ...